BOSTON SCIENTIFIC CORP — Director's Dealing 2023

Dec 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2023-12-01

Reporting Person: Monson Jonathan (SVP, Global Controller and CAO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-01	Restricted Stock Units	$	A	3562.0000	Acquired	2026-12-01	Common Stock (3562.0000)	Direct
2023-12-01	Stock Option (Right to Buy)	$56.1400	A	10543.0000	Acquired	2033-12-01	Common Stock (10543.0000)	Direct

Footnotes

F1: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Shares of common stock will be issued to the reporting person in full on December 1, 2026, the third anniversary of the date of grant.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in full on December 1, 2026, the third anniversary of the date of grant.